| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 19, 2025 | Virtual Patients: How AI Simulation Is Revolutionizing Clinical Trials and Drug Development
Enter the Virtual Patient
Why Now?
The Risks Are Real and So Are the Responsibilities
Where the Smart Capital Should Flow
The Future Isn’t Virtual… But It Will Be Simulated | Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long... |
| Feb 14, 2023 | Doing More with Moore: Biotech’s Tech Moment | Eroom’s Law (the backwards Moore) is the often cited, and arguably inaccurate, observation that drug discovery gets slower and more expensive over time. It’s certainly a slog, but R&D efforts have yielded 378 new FDA-approved drugs betw... |
| Jan 13, 2022 | Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X | What You Should Know:
– New data from Tufts and Medable reveal on average, decentralized clinical trials (DCTs) are associated with reduced clinical trial timelines and can achieve net financial benefits ranging from five to 14 times for Ph... |
| Jun 28, 2021 | Hospitals Can Teach Life Science Companies a Thing or Two About Patient Engagement | Greg Kefer, Chief Marketing Officer at Lifelink Systems
The efforts to develop a COVID-19 vaccine focused the world’s attention on the pharmaceutical industry. Before the pandemic hit, very few people outside of the healthcare industry unde... |
| Mar 9, 2021 | How Covid-19 is changing rare diseases research | Twenty years after researchers published their first discoveries associated with human genome sequencing, policymakers are fighting to overcome obstacles that hobble the potential of genetic medicine to recognize, diagnose and cure rare dis... |
| Sep 21, 2020 | The world is racing toward Covid-19 drugs. In normal times, it takes years to get new antivirals out the door | Researchers may be racing to develop new Covid-19 treatments, but normally it has taken slightly more than six years, on average, to test new anti-viral medicines and then win U.S. regulatory approval, according to a new analysis of anti-in... |
| May 7, 2019 | Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds | Clinical operations function makes the highest use of artificial intelligence (AI) (61%), followed by pharmacovigilance/safety/risk management (57%), and information technology (IT) (55%), according to an analysis recently completed by the ... |
| Jan 11, 2019 | Virtual repurposing can speed the discovery of new uses for existing drugs | The process for discovering drugs tends to be based on the same kind of pigeonholing that doctors use to treat disease: Parkinson’s is one disease, Crohn’s is something completely separate. A new approach, sometimes called virtual repurposi... |
| Dec 30, 2017 | Bigfinite Raises $8.5 Million Seed Round to Help Pharma Industry Optimize its Drug Manufacturing Process | Bigengine Saas Platform Uses Data Analytics and Artificial Intelligence Technologies to Make Pharma Manufacturing More Efficient
Related Posts
Optiv ‘A Visual Future of Cybersecurity’ Prepares Business Leaders for the Next Era of Attacks an... |
| Sep 8, 2017 | Three approaches to enhancing clinical trial recruitment | Organizations such as the Michael J Fox Foundation have been able to save money and make recruitment more efficient by advertising for clinical trials on the website. Last year MJFF found they were able to save a boatload on the cost of ads... |
| Aug 16, 2017 | Who gets all that biopharma lobbying money? | As the winds shift in Washington, here’s something to depend on: Big pharma and health products companies will be the top spenders on lobbying, and the competition isn’t close. Since 1998, they have doled out $3.7 billion to convince, cajol... |
| Jun 21, 2017 | Landmark FDA approval bolsters personalized medicine | Our understanding of cancer has been morphing from a tissue-specific disease — think lung cancer or breast cancer — to a disease characterized more by specific genes or biomarkers than by location. A recent FDA decision underscores that tra... |
| Jul 27, 2016 | Government listing of clinical trials doesn’t disclose costs to patients | Last summer, Linda Smith learned she was losing significant cartilage in her knees, a consequence of her lifelong love of skiing, running, and ultimate frisbee. Diagnosed with osteoarthritis, she wanted to avoid surgery and was eager to con... |
| May 13, 2016 | Drug coupons and fewer covered medicines tell a story of rising prices | As drug makers issue more coupons to help consumers lower their costs, a new study finds that the companies providing prescription coverage are fighting back by refusing to cover more medicines. And the tactics underscore the jockeying for ... |
| May 6, 2016 | Garage Biotech: New drugs using only a computer, the internet and free online data | |
| Feb 4, 2016 | The Shkreli smirk effect: 5 congressional rants from today’s drug pricing hearing | “Turing followed most of the consultant’s advice, except for one glaring exception – you never lowered the price of Daraprim,” Cummings spat. “This email indicates that despite the promises of lowering the price internally, Turing has no de... |
| Feb 3, 2016 | Misfit Vets Out to Debug Science Experiments With Elemental Machines | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
You’ve heard of the smart home. You probably haven’t heard of the smart lab. Until now, that is.
The idea is analogous to a connected home: you hook up a science lab with sens... |
| Sep 29, 2015 | Drug firms need to explain the prices | This weekly column offers opinions on the latest pharmaceutical industry news.
Like it or not, Martin Shkreli is the new face of pharma. And for an industry already struggling with an image problem over the rising costs of prescription drug... |
| Jun 3, 2015 | YC Alum Atomwise Raises $6 Million To Further The Advancement Of Artificial Intelligence In Drug Discovery | Drug discovery platform Atomwise has raised $6 million in seed funding to dig deeper into artificial intelligence and potentially speed up the process in which we discover new drugs.
The funding came from VC firms that all have some sort of... |
| Jun 1, 2015 | Why do cancer drug costs keep shooting up? Fuzzy math. | Why can’t we get a handle on these ever-inflating cancer drug costs? Here’s your simplified answer: Fuzzy math.
A top oncologist’s criticisms of cancer drug costs seems to have hit a nerve among the scads of doctors and cancer execs at ASCO... |
| May 3, 2013 | Breast cancer drug with companion diagnostic head for clinical trials | Personalized medicine is continuing to evolve to the point where we have drug makers developing drugs that come with a companion diagnostic, developed with the help of a diagnostic partner. Arno Therapeutics is developing a personalized the... |
| Jan 22, 2013 | IT startup helps clinical trial ecosystem communicate | The bootstrapped company recently moved from a shared workspace to its own office on Church Street in Philadelphia. After launching its first version in 2010, it introduced its third iteration of the cloud-based platform last year. In an in... |
| Feb 23, 2011 | Personalized medicine to be focus of new Indiana institute | Much of the future of health care is in personalized medicine, meaning more precise targeting of the right medication to the right patient at the right time. We believe it should lead to cost benefits — it clearly will be better for patient... |
| Nov 15, 2010 | Nonprofit takes risk out of device development for Medtronic | For companies like Medtronic Inc. (NYSE:MDT), developing breakthrough technologies to treat untreatable diseases can be expensive and have little promise of financial returns.
The risk is high enough for — even companies as well-resourced a... |
| Nov 12, 2010 | Medtronic’s research partnership: a roadmap to the future? | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| Feb 4, 2010 | Mayo Clinic looks to tap EMR database to craft clinical trials | By Thomas Lee
ROCHESTER, Minnesota – When a clinical drug trial fails — and they often do — everyone loses. Patients don’t receive new treatments. Companies, investors, and hospitals see precious time, money, and resources evaporate into sm... |
| Feb 3, 2010 | Mayo Clinic collaborates with start-up company to speed clinical trials | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| Jul 28, 2009 | Kendle International realigns executives to drive innovation, productivity, efficiency | Bergen led Kendle’s recent enterprise resource planning (ERP) initiative, which is winding to a close. It was the largest initiative in the company’s history and is expected to yield benefits such as streamlined global processes, enhanced ... |
| Jun 1, 2009 | Kendle expands clinical research offices throughout Southeast Asia | Kendle, based in Cincinnati, has operated in Asia since 1998 and already has a total of eight offices in China, India, Singapore and Australia. The company is able to perform all phases of clinical trials throughout the globe, though it per... |
| The past, present, and future of drug development: What’s causing its current transformation? | With a pounding head, an exhausted individual plods to the medicine cabinet in search of aspirin. The bottle says, “Take as directed,” so they pop two, followed by a few gulps of water, and wait the 15 to 20 minutes to feel some relief. The... |
| IT startup helps clinical trial ecosystem communicate | One of the biggest challenges to working remotely is communication. That’s particularly true of clinical trials that have become increasingly complex as management of these trials has shifted to contract research organizations and technical... |
| Mayo Clinic collaborates with start-up company to speed clinical trials | Image via Wikipedia
ROCHESTER, Minnesota — When a clinical drug trial fails — and they often do — everyone loses. Patients don’t receive new treatments. Companies, investors and hospitals see precious time, money and resources evaporate int... |
| Personalized medicine to be focus of new Indiana institute | Earlier this month, Indiana University announced a major commitment to research in one of healthcare’s most promising fields, personalized medicine. The Indiana Institute for Personalized Medicine will pursue genome-based and pharmacogenomi... |
| Why do cancer drug costs keep shooting up? Fuzzy math. | Why can’t we get a handle on these ever-inflating cancer drug costs? Here’s your simplified answer: Fuzzy math.
A top oncologist’s criticisms of cancer drug costs seems to have hit a nerve among the scads of doctors and cancer execs at ASCO... |
| Three approaches to enhancing clinical trial recruitment | Given that clinical trials represent the biggest pain point for drug development from the painstakingly slow recruitment process and the need to find the most suitable candidates, it’s interesting to see how companies are taking on the chal... |
| Medtronic’s research partnership: a roadmap to the future? | For companies like Medtronic Inc. (NYSE:MDT), developing breakthrough technologies to treat untreatable diseases can be risky and expensive. That’s why it’s nice to have a little bit of help from your friends.
Actually, make that a lot of h... |
| The Shkreli smirk effect: 5 congressional rants from today’s drug pricing hearing | Martin Shkreli, as predicted, invoked the Fifth Amendment and kept uncharacteristically quiet during today’s House of Representatives hearing on drug prices. However, his demeanor alone ruffled congressional feathers – with Rep. John Mica (... |
| Breast cancer drug with companion diagnostic head for clinical trials | Personalized medicine is continuing to evolve to the point where we have drug makers developing drugs that come with a companion diagnostic, developed with the help of a diagnostic partner. Arno Therapeutics is developing a personalized the... |
| Kendle expands clinical research offices throughout Southeast Asia | Updated: 7:50 p.m.
CINCINNATI, Ohio — The clinical research company Kendle has added locations in the capital cities of Malaysia, Philippines and Thailand — betting with the rest of the industry that more medical trials will take place outs... |
| Kendle International realigns executives to drive innovation, productivity, efficiency | CINCINNATI, Ohio — Kendle International Inc. on Tuesday announced an executive realignment as the latest in a series of efforts to better position the company as a top-tier, global contract research organization.
The company that provi... |
| How Covid-19 is changing rare diseases research | Twenty years after researchers published their first discoveries associated with human genome sequencing, policymakers are fighting to overcome obstacles that hobble the potential of genetic medicine to recognize, diagnose and cure rare dis... |
